Dasatinib And Placebo Medication Supply (Matodextrin) For The Development Of Phase Ii Clinical Trial Financed By The Mpy 110/25 Project

Name: Dasatinib And Placebo Medication Supply (Matodextrin) For The Development Of Phase Ii Clinical Trial Financed By The Mpy 110/25 Project
Start: 2025-05-31
End: 2025-06-20
Location: Secretaria General del Instituto de Salud Carlos III

Secretaria General del Instituto de Salud Carlos III Spain has Released a tender for Dasatinib And Placebo Medication Supply (Matodextrin) For The Development Of Phase Ii Clinical Trial Financed By The Mpy 110/25 Project in Pharmaceuticals. The tender was released on May 30, 2025.

Country - Spain

Summary - Dasatinib And Placebo Medication Supply (Matodextrin) For The Development Of Phase Ii Clinical Trial Financed By The Mpy 110/25 Project

Deadline - Jun 20, 2025

GT reference number - 110016066

Product classification - Various medicinal products

Organization Details:

Address - Spain

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 110016066

Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Dasatinib and placebo medication supply (Matodextrin) for the development of phase II clinical trial financed by the MPY 110/25 projectlocal title:: Suministro del medicamento dasatinib y placebo (matodextrina) para el desarrollo del ens ayo clínico de fase II financiado por el proyecto MPY 110/25Contract Type: : Supplylocal description: : Suministro del medicamento dasatinib y placebo (matodextrina) para el desarrollo del ensayo clínico de fase II financiado por el proyecto MPY 110/25Gross Budget Euro: : 140000.0Net Budget Euro: : 140000.0Gross Budget LC: : 140000.0Net Budget LC: : 140000.0Tender URL: : https://contrataciondelestado.es/wps/poc?uri=deeplink%3AperfilContratante&

Gt Ref Id - 110016066

Deadline - Jun 20, 2025